GMP/API Peptides
RS Synthesis provides cGMP peptide manufacturing according to FDA 21 CFR parts 210 & 211, following ICH Q7A Good Manufacturing Practices.
FDA registered, dedicated facilities for API manufacturing, including both SOLID and SOLUTION phase synthesis, purification, lyophilization, and packaging are the foundation of the quality systems in place for GMP peptide production.
Class 300,000/100,000/10,000 clean rooms, and on-site water treatment facilities round out the comprehensive GMP Petpide and API manufacturing services offered.
SMALL SCALE cGMP
Mg to gram quantities, perfect for:
- Animal toxicity studies
- Small clinical trials
- Novel immunotherapy approaches
- Personalized peptide vaccination (PPV) trials
- Right to Try” or “Expanded Access”
LARGE SCALE cGMP
5L to 350L+ Reaction Vessel Capacities available.
- Multi-gram, and multi-kg GMP peptide manufacturing expertise
- Large scale single lot capability
- Validated raw materials and equipment
- Custom and Standard CoA packages
- Specific Batch Records available (see Sample Technical Package)
- ICH storage and stability studies
Benefits Include:
- Multi-channel synthesis allowing high volume sequence trials
- Fast production and purification per individual set of sequences
- TFA, Acetate, or HCL salts
- High success rate
- Endo-tox and sterility testing provided
- Low cost
Typical Analyses for GMP peptides
- Appearance
- Purity by gradient HPLC
- MW by mass spec
- Peptide content
- Counter Ion content
- Water content
- Residual organic solvent content
- Endotoxin / Micro-bio
GMP Peptides
Strict quality control adherence for utmost product integrity
Full range of SOP’s meeting clinical production guidelines, SOP index
Full technical support, DMF, Module 3.
Competitive pricing as a result of scale-up expertise